| Clear Cell Sarcoma of Soft Tissue studied in …STUDIED_INderived25 of 25show fewer |
|---|
| → studied in | NCT02867592Phase 2 · active not recruiting Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors · condition mapped ONTOLOGY_EXACT · 25 trials mapped (11 active) | — | — | Clear Cell Sarcoma of Soft Tissue | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06239272Phase 1/Phase 2 · recruiting NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS) · condition mapped ALIAS · 25 trials mapped (11 active) | — | — | Clear Cell Sarcoma of Soft Tissue | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04458922Phase 2 · active not recruiting Testing Atezolizumab in People 2-17 Years Old With Clear Cell Sarcoma or Advanced Chondrosarcoma · condition mapped CURATED_BROADER · 25 trials mapped (11 active) | — | — | Clear Cell Sarcoma of Soft Tissue | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06625190Phase 1/Phase 2 · recruiting Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors · condition mapped ALIAS · 25 trials mapped (11 active) | — | — | Clear Cell Sarcoma of Soft Tissue | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02180867Phase 2/Phase 3 · completed Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery · condition mapped ONTOLOGY_EXACT · 25 trials mapped (11 active) | — | — | Clear Cell Sarcoma of Soft Tissue | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04897321Phase 1 · recruiting B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR) · condition mapped ALIAS · 25 trials mapped (11 active) | — | — | Clear Cell Sarcoma of Soft Tissue | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04483778Phase 1 · active not recruiting B7H3 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults · condition mapped ALIAS · 25 trials mapped (11 active) | — | — | Clear Cell Sarcoma of Soft Tissue | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03967834NA · recruiting Multimodal Immune Characterization of RAre Soft Tissue Sarcoma - MIRAS Project From SARRA (SARcome RAre) Project of the French Sarcoma Group · condition mapped ALIAS · 25 trials mapped (11 active) | — | — | Clear Cell Sarcoma of Soft Tissue | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06942442Phase 2 · recruiting A Phase II Trial of Tebentafusp in HLA-A*02:01 Positive Patients With Advanced Clear Cell Sarcoma · condition mapped ALIAS · 25 trials mapped (11 active) | — | — | Clear Cell Sarcoma of Soft Tissue | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03618381Phase 1 · active not recruiting EGFR806 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults · condition mapped ALIAS · 25 trials mapped (11 active) | — | — | Clear Cell Sarcoma of Soft Tissue | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02162732NA · completed Molecular-Guided Therapy for Childhood Cancer · condition mapped ALIAS · 25 trials mapped (11 active) | — | — | Clear Cell Sarcoma of Soft Tissue | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07153887Phase 2 · recruiting Vebreltinib for Advanced or Metastatic CCS · condition mapped ALIAS · 25 trials mapped (11 active) | — | — | Clear Cell Sarcoma of Soft Tissue | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06526897NA · not yet recruiting Evaluation of Chest CT Versus Chest X-Ray for Lung Surveillance After Curative-Intent Resection of High-Risk Truncal-Extremity Soft Tissue Sarcoma · condition mapped ONTOLOGY_EXACT · 25 trials mapped (11 active) | — | — | Clear Cell Sarcoma of Soft Tissue | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03132155Phase 2 · terminated QUILT-3.031: AMG 337 in Subjects With Advanced or Metastatic Clear Cell Sarcoma · condition mapped ALIAS · 25 trials mapped (11 active) | — | — | Clear Cell Sarcoma of Soft Tissue | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04274023Phase 2 · terminated Study on TSR-042 in Advanced Clear Cell Sarcoma · condition mapped ALIAS · 25 trials mapped (11 active) | — | — | Clear Cell Sarcoma of Soft Tissue | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03600649Phase 1 · unknown Clinical Trial of SP-2577 (Seclidemstat) in Patients With Relapsed or Refractory Ewing or Ewing-related Sarcomas · condition mapped ALIAS · 25 trials mapped (11 active) | — | — | Clear Cell Sarcoma of Soft Tissue | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05266196Phase 1/Phase 2 · unknown A Rollover Protocol to Allow for Continued Access to the LSD1 Inhibitor Seclidemstat (SP-2577) · condition mapped ALIAS · 25 trials mapped (11 active) | — | — | Clear Cell Sarcoma of Soft Tissue | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05963035NA · unknown Clinical Application of 18F-PFPN PET Imaging in Diagnosis and Staging of Clear Cell Sarcoma of Soft Tissue · condition mapped ONTOLOGY_EXACT · 25 trials mapped (11 active) | — | — | Clear Cell Sarcoma of Soft Tissue | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04593758Phase 1/Phase 2 · completed To Evaluate Maximally Tolerated Dose (MTD), Safety and Efficacy of CPI-613® (Devimistat) Plus Hydroxychloroquine in Patients With Relapsed or Refractory Clear Cell Sarcoma of Soft Tissue · condition mapped ALIAS · 25 trials mapped (11 active) | — | — | Clear Cell Sarcoma of Soft Tissue | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00258687Phase 1 · completed Vaccine Trial for Clear Cell Sarcoma, Pediatric Renal Cell Carcinoma, Alveolar Soft Part Sarcoma and Children With Stage IV Melanoma · condition mapped ALIAS · 25 trials mapped (11 active) | — | — | Clear Cell Sarcoma of Soft Tissue | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03989596Phase 2 · unknown Hypofractionated Radiotherapy With Hyperthermia in Unresectable or Marginally Resectable Soft Tissue Sarcomas · condition mapped ALIAS · 25 trials mapped (11 active) | — | — | Clear Cell Sarcoma of Soft Tissue | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02968303Phase 2 · unknown Induction Therapy With Vemurafenib and Cobimetinib to Optimize Nivolumab and Ipilimumab Therapy · condition mapped ALIAS · 25 trials mapped (11 active) | — | — | Clear Cell Sarcoma of Soft Tissue | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01331135Phase 1 · completed Aflac ST0901 CHOANOME - Sirolimus in Solid Tumors · condition mapped ALIAS · 25 trials mapped (11 active) | — | — | Clear Cell Sarcoma of Soft Tissue | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02390843Phase 1 · completed Simvastatin With Topotecan and Cyclophosphamide in Relapsed and/or Refractory Pediatric Solid and CNS Tumors · condition mapped ALIAS · 25 trials mapped (11 active) | — | — | Clear Cell Sarcoma of Soft Tissue | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00557609Phase 2 · completed Phase 2 Study in Patients With MiT Tumors · condition mapped ALIAS · 25 trials mapped (11 active) | — | — | Clear Cell Sarcoma of Soft Tissue | 1 | Observed | clinicaltrials | graph → |